Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
OHSU Knight Cancer Institute
Coordinación de Investigación en Salud, Mexico
Virginia Commonwealth University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
University of Washington
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Medical College of Wisconsin
M.D. Anderson Cancer Center
European Institute of Oncology
National Cancer Institute (NCI)
European Institute of Oncology
Washington University School of Medicine
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Northwestern University
Oslo University Hospital